CLINICAL_TRIALS
trial_result
· 2017-04-12
Clinical Trial Update: Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease
Summary
A completed clinical trial assessing whether Type 2 diabetes mellitus acts as a catalyst for Alzheimer's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Alzheimer´s Disease, Diabetes Mellitus Type 2 | Status: COMPLETED